RICE HALL JAMES & ASSOCIATES LLC
Q3 2026 Form 13-F

SAN DIEGO, CALIFORNIA
CIK 0001230765 · CRD 125410 · SEC-registered investment adviser
$1.9B Reported Value Total

RICE HALL JAMES & ASSOCIATES LLC reports 249 total accounts under management (AUM). There are 249 discretionary accounts valued at $1,740,251,833, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
1 fund · $15.9M gross asset value
Hedge Fund: $15.9M
Source: Form ADV filed 2026-05-06
Reported value
$1.9B
Quarter over quarter
-6.1%
Holdings
237
Top-10 concentration
22.4%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Thuong-Thao Nguyen Buu-Hoan
MANAGING MEMBER, CHIEF OPERATING OFFICER, PRESIDENT
Louis Millett Holtz
MANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER
Yossef Ytzhak Lipsker
MANAGING MEMBER, PORTFOLIO MANAGER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 16, 2026
Form 13F-HR
Reported value $1.9B
Positions 237
Change in reported value -8.2%
New positions 10
Exited positions 13
Position turnover 9.2%
Top-10 concentration 22.4%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
237 $1.9B
Q2 2026 13F
Filed Aug 7, 2026
240 $2.1B
Q1 2026 13F
Filed May 15, 2026
243 $1.8B
Q4 2025 13F
Filed Feb 17, 2026
243 $1.8B
Q3 2025 13F
Filed Oct 16, 2025
248 $1.8B
Q2 2025 13F
Filed Aug 11, 2025
247 $1.9B
Q1 2025 13F
Filed May 1, 2025
248 $1.7B
Q4 2024 13F
Filed Jan 31, 2025
249 $1.8B
Q3 2024 13F
Filed Oct 28, 2024
250 $1.8B
Q2 2024 13F
Filed Aug 7, 2024
256 $1.7B
Q1 2024 13F
Filed Apr 23, 2024
257 $1.8B
Q4 2023 13F
Filed Feb 9, 2024
260 $1.7B
Q3 2023 13F
Filed Nov 2, 2023
260 $1.6B
Q2 2023 13F
Filed Jul 24, 2023
262 $1.8B
Q1 2023 13F
Filed May 12, 2023
262 $1.8B
Q4 2022 13F
Filed Jan 27, 2023
260 $1.7B
Q3 2022 13F
Filed Nov 1, 2022
265 $1.7B
Q2 2022 13F
Filed Aug 8, 2022
265 $2.1B
Q1 2022 13F
Filed May 5, 2022
306 $2.5B
Q4 2021 13F
Filed Feb 14, 2022
312 $2.8B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 LGND LIGAND PHARMACEUTICALS INC $69.9M 3.71%
2 ACIW ACI WORLDWIDE INC $47.7M 2.53%
3 ARLO ARLO TECHNOLOGIES INC $45.3M 2.4%
4 ZD ZIFF DAVIS INC $45.1M 2.39%
5 XPO XPO INC $38.6M 2.05%
6 FN FABRINET $36.3M 1.93%
7 FOUR SHIFT4 PMTS INC $35.2M 1.87%
8 DFIN DONNELLEY FINL SOLUTIONS INC $34.9M 1.85%
9 PBH PRESTIGE CONSMR HEALTHCARE I $34.8M 1.85%
10 KNSA KINIKSA PHARMACEUTICALS INTL $34.8M 1.84%
11 LRN STRIDE INC $33.5M 1.77%
12 ASND ASCENDIS PHARMA A/S $33.1M 1.75%
13 MEDP MEDPACE HLDGS INC $33.0M 1.75%
14 ESTA ESTABLISHMENT LABS HLDGS INC $32.7M 1.73%
15 GDDY GODADDY INC $30.9M 1.64%
16 WIX WIX COM LTD $29.8M 1.58%
17 WEX WEX INC $29.8M 1.58%
18 AWI ARMSTRONG WORLD INDS INC NEW $28.1M 1.49%
19 G GENPACT LIMITED $27.7M 1.47%
20 EEFT EURONET WORLDWIDE INC $25.8M 1.37%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings